Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

KP-1461 safe and well tolerated in phase I study in HIV patients

Oct. 11, 2007

Synergy seen with SQ-109 and rifampin against Mycobacterium tuberculosis

Oct. 11, 2007

MK-0859 improves LDL- and HDL-cholesterol in large dyslipidemia study

Oct. 11, 2007

SLx-4090 lowers postprandial triglycerides, LDL-cholesterol in healthy men

Oct. 11, 2007

OXI-4503 well tolerated in ongoing phase I study

Oct. 11, 2007

Potent innate immune responses triggered by novel cationic lipid DNA complex adjuvant

Oct. 11, 2007

Anticancer efficacy of ZK-EPO in preclinical ovarian cancer models and in patients with NSCLC

Oct. 11, 2007

Peglyation increases and prolongs systemic exposure of irinotecan and its active metabolite in rats

Oct. 11, 2007

Identification and preclinical characterization of a novel EGFR/SRC inhibitor SI-35

Oct. 11, 2007

Improved lipid profile and insulin sensitivity by MBX-213, a novel dual PPARalpha/gamma agonist

Oct. 10, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...